SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-15-200255
Filing Date
2015-05-26
Accepted
2015-05-26 17:02:06
Documents
2
Group Members
AGTC PARTNERS, L.P.APPLIED GENOMIC TECHNOLOGY CAPITAL FUND, L.P.EDWIN M. KANIA, JR.FLAGSHIP VENTURES 2007 GENERAL PARTNER, LLCFLAGSHIP VENTURES FUND 2007, L.P.FLAGSHIP VENTURES MANAGEMENT, INC.NEWCOGEN GROUP, INC.NOUBAR B. AFEYAN, PHD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d931485dsc13da.htm SC 13D/A 215492
2 EX-1 d931485dex1.htm EX-1 11365
  Complete submission text file 0001193125-15-200255.txt   228687
Mailing Address ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
AGTC ADVISORS FUND LP (Filed by) CIK: 0001131095 (see all company filings)

IRS No.: 522266955
Type: SC 13D/A

Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Subject) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86104 | Film No.: 15890079
SIC: 2835 In Vitro & In Vivo Diagnostic Substances